Sterling Consolidated Corp. STCC
Last Post: 11/29/2018 11:18:53 AM
Board Marks: 4
Posts Today: 0
Board Views Today: 23
10/18/2016 1:58:29 PM
10/18/2016 12:34:47 PM
10/18/2016 12:32:02 PM
10/18/2016 11:20:24 AM
10/18/2016 11:19:00 AM
10/17/2016 4:56:04 PM
10/17/2016 4:55:08 PM
10/17/2016 4:53:23 PM
10/17/2016 4:52:18 PM
10/17/2016 11:35:28 AM
10/17/2016 11:33:54 AM
10/13/2016 12:36:17 PM
10/13/2016 12:33:06 PM
10/13/2016 12:31:24 PM
10/12/2016 4:52:26 PM
10/12/2016 3:00:54 PM
10/12/2016 2:59:21 PM
10/12/2016 2:59:13 PM
10/11/2016 5:25:48 PM
10/11/2016 5:24:26 PM
10/11/2016 1:47:23 PM
10/11/2016 1:45:33 PM
10/11/2016 1:44:40 PM
10/10/2016 5:10:03 PM
10/10/2016 5:07:45 PM
10/10/2016 5:04:55 PM
10/10/2016 12:31:53 PM
10/10/2016 12:30:24 PM
10/10/2016 12:29:29 PM
10/07/2016 2:13:31 PM
10/07/2016 2:13:15 PM
10/07/2016 12:39:32 PM
10/07/2016 12:37:16 PM
10/07/2016 12:35:36 PM
10/06/2016 4:35:42 PM
10/06/2016 4:33:01 PM
10/06/2016 4:30:37 PM
10/06/2016 12:28:05 PM
10/06/2016 12:24:51 PM
10/05/2016 5:35:51 PM
10/05/2016 2:57:29 PM
10/05/2016 2:56:21 PM
10/05/2016 2:55:36 PM
10/05/2016 2:55:08 PM
10/05/2016 2:54:16 PM
10/05/2016 2:53:42 PM
10/05/2016 2:53:02 PM
10/05/2016 12:19:21 PM
10/05/2016 12:17:55 PM
10/05/2016 10:45:44 AM
Recent Articles
- Nextensa and Promobe Secure Long-Term Lease for New Offices
- China's Rare Earth Controls: An Uncertain Gamble Ahead
- Transform Your Finances: The Military Money Manual Unveiled
- FORVIA Reports Steady Q3 2025 Sales of €6.1 Billion
- High-Dose Influenza Vaccine Promises Greater Protection for Seniors
- Corbion Share Buyback Program Update: Significant Progress Made
- Roche's Gazyva/Gazyvaro Receives FDA Approval for Lupus Nephritis
- Vow ASA Reports Mixed Q3 Performance Amid Strong Market Demand
- TGS Secures Major OBN Acquisition Contract for Gulf of America
- Advancements in Bladder Cancer Treatment: Roche's Tecentriq Impact
- Sanofi's High-Dose Flu Vaccine Outperforms Standard Dosage
- ARTIS Zoo's New Certification: A Win for Urban Wildlife
- Zeekr Group to Release Q3 Financial Results; What's Next?
- Comfone Unveils Global 5G Standalone Roaming Services
- ARTIS Zoo Becomes Europe's First Certified Night Sky Place
- Tim Cook Applauds China's Remarkable Contribution to Apple
- Highlights from the 2025 World Internet Conference Preview
- Exploring the Essence of China-South Korea Relations Through Art
- Marko Law Firm Expands Footprint to Better Serve Michigan Residents
- Quantitative Brokers Unveils Advanced Trading Solutions in Brazil
- HTX's Airdrop Initiative: Supporting Traders Amid Market Chaos
- Insights on the AI Boom: Evaluating Valuations and Investment Opportunities
- Kyndryl's Latest AI Readiness Insights Sparks Transformation
- Tesla's Upcoming Earnings: Focus on Robotaxis and AI Integration
- Trump's Warning: Supreme Court Ruling May Harm U.S. Economy
- BC.GAME Esports Welcomes CS Major Champion electronic to Squad
- Elon Musk Defends Tesla's CEO Compensation Amid Criticism
- Chery Group Strengthens Commitment to Global Education Initiatives
- Revolutionizing Workplace Comfort with Elevated Seating Innovation
- Established Tech Giants Poised to Lead in AI Development
- ENGWE's Innovative Journey: Connecting E-Bike Riders Worldwide
- Investigation Ongoing After Daring Jewelry Heist at Louvre
- Unveiling Sustainable Solutions: Insights from Global Leaders
- SKYWORTH Launches Revolutionary Matte Screen Ultra TV Series
- Exciting Advances in Lung Cancer Treatment with Sacituzumab Tirumotecan
- MoonLake Immunotherapeutics: A Call to Action for Investors
- Investors Urged to Act Quickly in PubMatic Class Action Suit
- Tragic Cargo Plane Incident at Hong Kong Airport Sparks Concerns
- Christine Lagarde's Insight: Upcoming Tariff Effects on U.S. Consumers
- Insights on the Upcoming Financial Street Forum in Beijing
- Antengene Advances ATG-022: Promising Clinical Outcomes Revealed
- Investigation Announcement for Baxter International Investors
- Cytokinetics Investors: Secure Representation Before Deadline
- Jasper Therapeutics Investors: Important Class Action Deadline Ahead
- Mesoblast Limited Reports Significant Revenue Growth After Ryoncil Launch
- CStone Pharmaceuticals Shares Promising Phase I Results for CS2009
- Ascletis Completes Enrollment in Phase IIa Study of ASC30.
- Innovations in Pancreatic Cancer Treatment with Satri-cel
- Cambodia's Techo International Airport: A Gateway to Growth
- Record Growth in Q2 Revenues Enhances Mesoblast's Market Position
